| Baseline | Treatment phase | Follow-up phase | ||
---|---|---|---|---|---|
Tasks | Week -2 | Week 0 | Week 3 | Week 5 | Week 8 |
Participants/next-of-kin | Â | Â | Â | Â | Â |
Informed consent | x | Â | Â | Â | Â |
Sign the proxy consent | x | Â | Â | Â | Â |
Obtain participant’s assent | x |  |  |  |  |
Access medical record | x | Â | Â | Â | Â |
Physical examination | x | Â | Â | Â | Â |
Intervention | Â | Â | Â | Â | Â |
Acupressure group (n =33) | Â | x | Â | Â | Â |
Control | Â | Â | Â | Â | Â |
Sham-acupressure group (n =33) | Â | x | Â | Â | Â |
Usual-care group (n =33) | Â | x | Â | Â | Â |
Outcomes | Â | Â | Â | Â | Â |
Agitation (CMAI) | Â | x | x | x | x |
Stress (salivary cortisol) | Â | x | x | x | x |
Monitoring | Â | Â | Â | Â | Â |
Compliance with the intervention | Â | x | Â | Â | Â |
Reasons for withdrawal | Â | x | x | x | x |
Adverse events/safety | Â | x | x | x | x |